Track topics on Twitter Track topics that are important to you
Phone: 1 312-755-0798
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, a...
CAMBRIDGE, Mass., March 09, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced t...
CARMIEL, Israel, March 15, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development and commercialization o...
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anast...
BioCentury has pioneered the creation of turf-neutral, independent venues for the corporate and investment communities to conduct business. As a result, these events are known by the quality of their ...
ScarX Therapeutics is a Toronto-based life sciences company founded in partnership with The Hospital for Sick Children and MaRS Innovation, which discovers and develops innovative...
This century is already being coined the ‘Biocentury', as the fruits of fifty years of research in the field of molecular biology begin to affect our world. Medical advances over the next hundred ye...
We have published hundreds of BioCentury news stories on BioPortfolio along with dozens of BioCentury Clinical Trials and PubMed Articles about BioCentury for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioCentury Companies in our database. You can also find out about relevant BioCentury Drugs and Medications on this site too.